CD11/CD18 Leukocyte Integrins: New Signaling Receptors for Bacterial Endotoxin
Open Access
- 30 November 1997
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 73 (1) , 85-89
- https://doi.org/10.1006/jsre.1997.5195
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Resistance to Endotoxin Shock and Reduced Dissemination of Gram-Negative Bacteria in CD14-Deficient MiceImmunity, 1996
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994
- The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands.The Journal of cell biology, 1993
- Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms.Journal of Clinical Investigation, 1992
- Recognition and plasma clearance of endotoxin by scavenger receptorsNature, 1991
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide.The Journal of Experimental Medicine, 1989
- ENDOTOXINS AND DISEASE MECHANISMSAnnual Review of Medicine, 1987
- Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide.The Journal of Experimental Medicine, 1986
- Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.The Journal of Experimental Medicine, 1982